QI
MED icon

QS Investors’s Medifast MED Stock Holding History

QS Investors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1.6M Buy
5,670
+1,800
+47% +$488K 0.02% 391
2021
Q1 		$820K Buy
3,870
+235
+6% +$56.2K 0.01% 585
2020
Q4 		$714K Buy
+3,635
New +$642K 0.01% 618
2020
Q3 		– Sell
-965
Closed -$134K – 1391
2020
Q2 		$134K Hold
965
– – ﹤0.01% 1234
2020
Q1 		$61K Hold
965
– – ﹤0.01% 1369
2019
Q4 		$108K Sell
965
-9,660
-91% -$935K ﹤0.01% 1365
2019
Q3 		$1.1M Sell
10,625
-10,486
-50% -$1.13M 0.01% 758
2019
Q2 		$2.71M Sell
21,111
-15,341
-42% -$2.13M 0.03% 481
2019
Q1 		$4.65M Sell
36,452
-533
-1% -$67.6K 0.05% 293
2018
Q4 		$4.62M Sell
36,985
-1,577
-4% -$270K 0.06% 236
2018
Q3 		$8.54M Sell
38,562
-600
-2% -$122K 0.08% 160
2018
Q2 		$6.27M Buy
39,162
+2,305
+6% +$295K 0.06% 220
2018
Q1 		$3.44M Sell
36,857
-2,346
-6% -$175K 0.04% 386
2017
Q4 		$2.74M Sell
39,203
-2,440
-6% -$162K 0.03% 492
2017
Q3 		$2.47M Sell
41,643
-773
-2% -$38.5K 0.02% 529
2017
Q2 		$1.76M Hold
42,416
– – 0.02% 624
2017
Q1 		$1.88M Sell
42,416
-19,200
-31% -$826K 0.02% 629
2016
Q4 		$2.56M Sell
61,616
-15,217
-20% -$613K 0.02% 551
2016
Q3 		$2.9M Buy
76,833
+4,820
+7% +$173K 0.02% 550
2016
Q2 		$2.4M Sell
72,013
-5,485
-7% -$177K 0.02% 600
2016
Q1 		$2.34M Buy
77,498
+20,300
+35% +$593K 0.02% 609
2015
Q4 		$1.74M Buy
57,198
+3,600
+7% +$107K 0.02% 690
2015
Q3 		$1.44M Buy
53,598
+35,678
+199% +$1.04M 0.02% 705
2015
Q2 		$579K Sell
17,920
-3,930
-18% -$125K 0.01% 855
2015
Q1 		$655K Buy
21,850
+19,750
+940% +$627K 0.01% 826
2014
Q4 		$71K Buy
+2,100
New +$65.4K ﹤0.01% 1175
2013
Q3 		– Sell
-17,800
Closed -$458K – 630
2013
Q2 		$458K Buy
+17,800
New +$468K 0.02% 537

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

QS Investors's MED Position: Q2 2021 in Review

QS Investors increased its Medifast (MED) stake by 47% in Q2 2021, buying an estimated $488K and bringing the position to 5,670 shares worth $1.6M. The position accounts for 0.02% of the portfolio, ranked #391.

QS Investors first reported a position in MED in Q2 2013 and has held it in 27 quarters since. The position peaked at $8.54M in Q3 2018. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

  • QS Investors held 5,670 shares of Medifast worth $1.6M as of Q2 2021.
  • QS Investors bought 1,800 Medifast shares in Q2 2021, an estimated $488K.
  • Medifast made up 0.02% of QS Investors's portfolio in Q2 2021, its #391 holding.
  • QS Investors first reported a position in Medifast in Q2 2013 and has held it in 27 quarters since.
  • QS Investors's Medifast position peaked at $8.54M in Q3 2018.
  • 301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.